The patent interference is related to certain pre-cooling technologies that CryoCor considers important to CryoCath’s cryoablation system. A patent interference is an administrative proceeding within the USPTO to establish which party was the first to invent certain subject matter and, therefore, should have patent rights to the technology.
Ed Brennan, president and CEO of CryoCor, said: “We believe we have broad coverage in our patent portfolio covering pre-cooling, which we consider important for a cryoablation system.”